GLE Appoints President and Chief Commercial Officer
TSX: CCO w e b s i t e : cameco.com
NYSE: CCJ currency: Cdn (unless noted)
2121 – 11th Street West, Saskatoon, Saskatchewan, S7M 1J3 Canada
Tel: 306-956-6200 Fax: 306-956-6201
GLE Appoints President and Chief Commercial Officer
Saskatoon, Saskatchewan, Canada, June 14, 2021 . . . . . . . . . . . . .
Highlights:
James Dobchuk appointed as the President and Chief Commercial Officer of Global Laser
Enrichment LLC (GLE)
Formerly Executive Director at Cameco Inc. engaged in key US-based strategy, corporate
development, project management, government and industry relations activities, very well
positioned to support GLE in its next phase of commercialization
Current Chair of the Nuclear Energy Institute’s Nuclear Fuel Suppliers Committee, a
Secretary of the Board of the Uranium Producers of America, and a member of the Executive
Committee of Radiant Energy Fund, LLC
Silex Systems Limited (Silex) (ASX: SLX; OTCQX: SILXY) and Cameco Corporation (Cameco)
(TSX: CCO; NYSE: CCJ) are pleased to announce the appointment of James Dobchuk as President
and Chief Commercial Officer of GLE, effective June 15, 2021.
James has over 20 years of experience in global uranium marketing and sales, including seven years
as President of Cameco’s US subsidiary, Cameco Inc., leading the company’s international sales and
marketing efforts. Most recently, James served as an Executive Director responsible for supporting
Cameco’s US-focused commercial interests and directing its government affairs activities in
Washington, DC. With his background and extensive experience in the global nuclear fuel markets,
he is well placed to lead the all-important customer-facing element of GLE’s prospective
commercialization phase.
“Following the successful completion of the GLE restructure in January 2021, Silex and Cameco
have focused on recruiting an executive team to lead GLE through its commercialization phase,” said
Craig Roy, Silex Chair and Chair of the GLE Governing Board. “We are delighted to have made the
first of these appointments, with James Dobchuk being selected as GLE’s President and Chief
Commercial Officer.
“James will lead GLE’s commercial and business development activities and will represent GLE with
key government and industry stakeholders. This includes driving GLE’s commercial opportunities,
including the Paducah project, and potentially positioning GLE as a provider of high-assay low-
enriched uranium (HALEU) for the emerging advanced reactor and small modular reactor markets,”
Mr. Roy said.
“We are very pleased to have someone with James’ vast experience and expertise in the nuclear
energy industry step into this important role,” said Cameco President and CEO Tim Gitzel. “He will
bring a strong commercial focus to GLE supported by his lengthy history in sales and marketing,
business development, international commerce and government relations across this sector.
- 2 -
“GLE is the exclusive licensee of next-generation SILEX laser uranium enrichment technology that
we believe has a bright future,” Mr. Gitzel said. “The ambitious climate commitments being made by
countries and companies around the world confirms that zero-carbon nuclear energy is on an upward
trajectory. Should this technology successfully proceed through development and into
commercialization, we feel we have the right person in place to help it establish a strong foundation
within that growing market.”
“I’m excited to be stepping into this role with GLE, a company leading the development of an
extraordinary technology that I feel is just beginning to scratch the surface of its tremendous
potential,” said James Dobchuk, GLE’s President and Chief Commercial Officer. “I’m proud to be
part of such an innovative, world-class team that is committed to moving this company forward, and
I’m very keen to get to work.”
About Global Laser Enrichment
The successful completion of the GLE restructure occurred on January 31, 2021 following the
conclusion of the US government approval process. The transaction involved the joint purchase of
GE-Hitachi’s (GEH) 76% interest in GLE by Silex and Cameco. Closing of the agreement resulted in
Silex acquiring a 51% interest in GLE and Cameco increasing its share from 24% to 49%, with the
option to attain a majority interest of 75% ownership.
The transaction included a site lease between GLE and GEH, which will enable GLE to complete the
SILEX technology commercialization program at the test loop facility in Wilmington, North
Carolina. This program is expected to culminate with the full-scale demonstration of the SILEX
uranium enrichment technology at the Wilmington site.
The Paducah Uranium Production Project (Paducah project)
Underpinning the Paducah project is the sales agreement between GLE and the US Department of
Energy (DOE), which provides GLE with access to large stockpiles of depleted uranium tails
inventories owned by DOE and located in Paducah, Kentucky. Subject to successful
commercialization of the SILEX technology, the Paducah project represents an ideal path to market.
This opportunity is expected to involve GLE constructing the proposed Paducah Laser Enrichment
Facility (PLEF), utilizing the SILEX technology to enrich the DOE tails inventories, which have been
stored in the form of depleted uranium hexafluoride. The potential for second stage processing of
PLEF output, involving enrichment from natural-grade uranium to low-enriched uranium for today’s
conventional nuclear reactor fleet and an additional stage for production of HALEU fuel for the next-
generation advanced reactor and small modular reactor markets, are currently being assessed.
Silex Profile
Silex is a research and development company whose primary asset is the SILEX laser enrichment
technology, which has been under development for uranium enrichment jointly with its US-based
exclusive licensee, GLE, for a number of years. Development operations continue in Sydney,
Australia and Wilmington, North Carolina at GLE’s Test Loop facility. Silex is also developing its
laser enrichment technology to produce enriched Silicon, a key enabling material for silicon quantum
computers. Silex is headquartered in Sydney, Australia.
Further information on the company’s activities can be found on the Silex website: www.silex.au.
- 3 -
Cameco Profile
Cameco is one of the largest global providers of the uranium fuel needed to energize a clean-air
world. Our competitive position is based on our controlling ownership of the world’s largest high-
grade reserves and low-cost operations. Utilities around the world rely on our nuclear fuel products to
generate power in safe, reliable, carbon-free nuclear reactors. Our shares trade on the Toronto and
New York stock exchanges. Our head office is in Saskatoon, Saskatchewan.
Caution Regarding Forward-Looking Information and Statements
This news release includes statements considered to be forward-looking information or forward-
looking statements under Canadian and US securities laws (which we refer to as forward-looking
information), including: the appointment of Mr. Dobchuk becoming effective on June 15, 2021; our
expectations that Mr. Dobchuk is well placed to lead the customer-facing element of GLE’s
commercialization phase, the role that he will play, and the focus that he will bring to that role; the
possibility of GLE becoming a provider of high-assay low-enriched uranium (HALEU) for the
emerging advanced reactor and small modular reactor markets; the expectation that GLE will
successfully complete the development of the SILEX technology; our beliefs regarding the future
prospects for next-generation laser enrichment technology and the ability of the technology licensed
by GLE to establish a strong market foundation; and the expectations regarding the Paducah project
and GLE’s ability to commercialize the SILEX technology.
This forward-looking information is based on a number of assumptions, including assumptions
regarding: Mr. Dobchuk’s ability to achieve the objectives of his role; the ability of GLE to complete
the development and commercialization of the SILEX technology; the extent of future market
demand for the SILEX technology, and its ability to compete against any similar or alternative
technology which may be developed; GLE’s ability to become a provider of HALEU for the intended
markets; and GLE’s ability to purchase depleted uranium from the DOE’s stockpiles in Paducah,
Kentucky and to construct the proposed laser enrichment facility using the SILEX technology. This
information is subject to a number of risks, including: the risk that Mr. Dobchuk will face unexpected
impediments in executing his responsibilities; the risk that GLE may not be able to complete the
development of the SILEX technology successfully or, once developed, may not be able to
commercialize it effectively; the risk of a decrease in future market demand for the SILEX
technology; the risk that other similar or alternative technologies may be developed, and may achieve
success in competing with the SILEX technology; the risk that GLE may not be able to become a
provider of HALEU for the intended markets; and the risk that GLE may not be able continue to have
access to the DOE’s depleted uranium stores in Paducah, Kentucky or that the proposed laser
enrichment facility may not be successfully completed. The forward-looking information in this news
release represents our current views, and actual results may differ significantly. Forward-looking
information is designed to help you understand our current views, and may not be appropriate for
other purposes. We will not necessarily update this information unless we are required to by
securities laws.
- End –
Investor inquiries:
Rachelle Girard
306-956-6403
Media inquiries:
Jeff Hryhoriw
306-385-5221